{
    "id": "246",
    "title": "Immune-Related Adverse Events for Endocrine Toxicities - Hypothyroidism",
    "desc": "The Immune-Related Adverse Events for Endocrine Toxicities - Hypothyroidism grades severity of hypothyroidism secondary to immune checkpoint inhibitor therapy.",
    "data": {
        "orgreference": [
            {
                "href": "https://www.ncbi.nlm.nih.gov/pubmed/29442540 ",
                "text": "Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714-1768."
            }
        ],
        "other_refer": [],
        "evidence": "<div dir=\"ltr\" align=\"left\">\n<table><colgroup><col /><col /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Criteria</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Hypothyroidism grade</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">TSH &lt;10 mIU/L and asymptomatic</p>\n</td>\n<td>\n<p dir=\"ltr\">G1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Moderate symptoms; able to perform ADLs; TSH persistently &gt;10 mIU/L</p>\n</td>\n<td>\n<p dir=\"ltr\">G2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Severe symptoms, medically significant or life-threatening consequences, unable to perform ADLs</p>\n</td>\n<td>\n<p dir=\"ltr\">G3-4</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p dir=\"ltr\">See Next Steps for details on management.</p>",
        "facts": "",
        "estimation": [],
        "primary_complains": [
            "Fatigue",
            "Weight Loss/Gain"
        ],
        "disease_treated": [
            "Hypothyroidism"
        ],
        "logic": "var calc_output = [];\n\nvar grading = parseFloat(grading);\nvar rec;\n\nswitch (grading) {\n  case 1:\n    rec = 'Continue ICPi with close follow-up, monitor TSH and FT4; see Next Steps for details';\n    break;\n  case 2:\n    rec = 'May hold ICPi until symptoms resolve; consult endocrinology; start thyroid hormone supplementation if symptomatic, or asymptomatic with TSH is persistently > 10 mIU/L; monitor TSH every 6-8 weeks; see Next Steps for details';\n    break;\n  case 3:\n    rec = 'Start thyroid hormone supplementation; Hold ICPi until symptoms resolve with supplementation; consult endocrinology; may admit for IV therapy if signs of myxedema; see Next Steps for details';\n    grading = '3-4';\n\n}\n\n//results\ncalc_output.push({\n    name: 'mini',\n    value: 'G'+grading,\n    value_text: '',\n    message: 'Hypothyroidism grade'   \n});\ncalc_output.push({\n    name: 'Score',\n    value: 'G'+grading,\n    value_text: '',\n    message: 'Hypothyroidism grade'   \n});\ncalc_output.push({\n    name: 'risk1',\n    value: '', \n    value_text: '',\n    message: rec\n});\n",
        "inputs": [
            {
                "conditionality": "",
                "default": null,
                "label_en": "Criteria",
                "name": "grading",
                "optional": false,
                "options": [
                    {
                        "label": "TSH <10 mIU/L and asymptomatic",
                        "value": 1
                    },
                    {
                        "label": "Moderate symptoms; able to perform ADLs; TSH persistently >10 mIU/L",
                        "value": 2
                    },
                    {
                        "label": "Severe symptoms, medically significant or life-threatening consequences, unable to perform ADLs",
                        "value": 3
                    }
                ],
                "show_points": false,
                "tips_en": "",
                "type": "radio"
            }
        ],
        "can_search": [
            "Immune Related Adverse Events, irae, hypothyroidism, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO"
        ],
        "specialty": [
            "Allergy and Immunology",
            "Endocrinology",
            "Hospitalist Medicine",
            "Internal Medicine"
        ]
    }
}